Patent: 8,067,396
✉ Email this page to a colleague
Summary for Patent: 8,067,396
Title: | Amino alcohol compounds or phosphonic acid derivatives thereof |
Abstract: | A compound having a formula II(a): ##STR00001## wherein R.sup.1 and R.sup.2 are hydrogen lower alkyl, lower aliphatic acyl, or lower alkoxycarbonyl; R.sup.4 is C.sub.1-C.sub.4 alkyl; n is 2 or 3; X is a formula .dbd.N-D, wherein D is hydrogen, C.sub.1-C.sub.6 alkyl or phenyl; Y is ethylene, ethynylene, --CO--CH.sub.2--, --CH(OH)--CH.sub.2-- or phenylene; Z is C.sub.1-C.sub.6 alkylene; R.sup.5 is C.sub.3-C.sub.10 cycloalkyl or C.sub.6-C.sub.10 aryl; R.sup.6 and R.sup.7 are hydrogen, lower alkyl, halogeno lower alkyl, lower alkoxy or lower alkylthio; and R.sup.10 and R.sup.11 are hydrogen or lower alkyl. |
Inventor(s): | Nishi; Takahide (Tokyo, JP), Shimozato; Takaichi (Miura, JP), Nara; Futoshi (Yachiyo, JP), Miyazaki; Shojiro (Tokyo, JP) |
Assignee: | Sankyo Company, Limited (Tokyo, JP) |
Application Number: | 12/460,884 |
Patent Claims: | see list of patent claims |
Details for Patent 8,067,396
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Janssen Biotech, Inc. | REMICADE | infliximab | For Injection | 103772 | 08/24/1998 | ⤷ Try a Trial | 2022-01-11 |
Immunex Corporation | ENBREL | etanercept | For Injection | 103795 | 11/02/1998 | ⤷ Try a Trial | 2022-01-11 |
Immunex Corporation | ENBREL | etanercept | For Injection | 103795 | 05/27/1999 | ⤷ Try a Trial | 2022-01-11 |
Immunex Corporation | ENBREL | etanercept | Injection | 103795 | 09/27/2004 | ⤷ Try a Trial | 2022-01-11 |
Immunex Corporation | ENBREL | etanercept | Injection | 103795 | 02/01/2007 | ⤷ Try a Trial | 2022-01-11 |
Immunex Corporation | ENBREL MINI | etanercept | Injection | 103795 | 09/14/2017 | ⤷ Try a Trial | 2022-01-11 |
Immunex Corporation | ENBREL | etanercept | Injection | 103795 | ⤷ Try a Trial | 2022-01-11 | |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |